Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report28 July 2016
Urenco UK has achieved a major milestone by being awarded the RoSPA Order of Distinction.
Ric Carrick Chief Nuclear Officer and Head of Safety, Health, Environment and Quality commented:
“UUK should be extremely proud of the contribution that they have made and use the award to support our continued commitment to ZERO HARM. This prestigious award which represents 15+ consecutive Gold Awards is a notable achievement and recognizes the collaborative working arrangements of Urenco UK Management, Employees and a wide range of Contractors in an ongoing commitment to Safety and Health.”
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries